MarketInOut Stock Screener Log In | Sign Up

Windlas Biotech Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:53
Windlas Biotech Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization18,009 mln
Float7.63 mln

EPS

31.26
Exceptional

P / E

28.43
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.38
Borderline

Relative Strength

48 / 100
In line with market

Debt / Equity

0.06
Debt-free

Business Description

Windlas Biotech Limited is an India-based pharmaceutical company founded in 2001 and headquartered in Dehradun that develops and manufactures a wide range of drug products for other companies. Its capabilities span tablets, capsules, injectable solutions, and complex formulations across therapeutic areas such as respiratory care, diabetes, heart health, and nutrition. The company also provides research, regulatory support, and custom formulation services, and exports medicines and health supplements to international markets.

Key Fundamentals

EPS31.26
P/E28.43
ROE12.30
RPS448
ROIC15.86
ROA7.99
Interest Cover13.73
EBITDA, mln1,226
EV / EBITDA16.57
EV / EBIT22.06
Revenue, mln9,421
EV / Revenue2.16

Quote Details

Last 888.70
Change 11.3 (1.29%)
Open 883.30
Volume 38,600
Turnover 34,303,820
Average Volume 80,036

Financial Ratios

Pre-Tax Profit Margin9
Current Ratio1.95
Price / Book3.95
Price / Tangible Book4.00
Price / Cash Flow32.20
Price / Free Cash Flow68.79
Debt / Equity0.06
Price / Sales2.46
PEG Ratio1.47

Financial Strength

Altman Z-Score6.34
Piotroski F-Score 4 / 9
Beneish M-Score-2.38
Price to Intrinsic Value3.21
Price to Lynch Fair Value1.39
Price to Graham Number2.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.84% 73 / 100   
1 Month -19.4% 8 / 100   
2 Months 0.93% 73 / 100   
6 Months 3.21% 68 / 100   
1 Year -3.43% 65 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog